Pricing Log in Create free account

Heatwurx Inc. (PCSA) vs Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Heatwurx Inc. and Reviva Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Heatwurx Inc. and Reviva Pharmaceuticals Holdings, Inc. are of similar size ($5.0M and $4.7M). Reviva Pharmaceuticals Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.6×. Across the 7 metrics below, Heatwurx Inc. leads on 4 and Reviva Pharmaceuticals Holdings, Inc. on 3.

Valuation

Metric PCSA RVPH Biotechnology median
P/E 1.61 n/m 8.50
P/S 35.49 n/m 9.71
P/B n/m 0.39 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.61 0.64
EV/Sales 45.29 n/m 9.21
Earnings yield 62.21% (268.98%) (33.15%)
Free cash flow yield (282.73%) (291.12%) (25.50%)

Profitability

Metric PCSA RVPH Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (464.19%) (176.60%) (56.36%)
Return on assets (262.17%) (79.46%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PCSA RVPH Biotechnology median
Revenue growth (TTM) (34.50%) — 6.02%
EPS growth (last fiscal year) 89.29% 69.56% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PCSA RVPH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.87 3.56 4.72
Net debt to EBITDA 0.40 0.71 0.96

Dividend

Metric PCSA RVPH Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PCSA RVPH Biotechnology median
Market cap 4.70m 5.00m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack